Lyons, France

Marco Natuzzi

This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignees: Centre National De La Recherche SCENTIFIQUE—CNRS, Hospice Civils De Lyon, Inserm (Institut National De La Santé De La Médicale). Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marco Natuzzi. Retrieved from https://idiyas.com/inventor/marco-natuzzi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marco Natuzzi: Innovator in Medical Device Technology

Introduction: Marco Natuzzi is an inventor based in Lyon, France. He has made significant contributions to the field of medical devices, focusing on technologies that address the extraction of metal cations and target molecules within the human body. Although he currently holds no granted patents, his innovative ideas are reflected in his latest patent applications.

Latest Patent Applications: Marco Natuzzi's recent patent applications include two notable inventions. The first is titled "Device for Joint Extraction of a Metal Cation and a Target Molecule." This invention pertains to medical devices designed for the simultaneous extraction of at least one metal cation and one target molecule within an organism. The device features a ligand with specific affinity for the target molecule and a perfusion fluid containing a chelating agent for the metal cation. This technology aims to prevent and treat pathologies related to the dysregulation of metal homeostasis and target molecules, such as neurological diseases and proteinopathies.

The second application is for a "Composition for Capturing Lead and/or Cadmium in a Dialysis Fluid." This invention focuses on a method for treating dialysis water and fluids to capture toxic metals like lead, aluminum, chromium, nickel, and cadmium. The dialysis composition includes a polymer with a weight-average molecular weight between 20 kDa and 1000 kDa, which contains a chelating agent for the toxic metals. This innovation is crucial for preventing the passage of these harmful substances into a patient's bloodstream during dialysis procedures.

Conclusion: Marco Natuzzi's work in medical device technology showcases his commitment to addressing critical health issues through innovative solutions. His latest patent applications reflect his expertise and potential impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…